Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 202

Similar articles for PubMed (Select 23810058)

1.

Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis.

Tricco AC, Soobiah C, Antony J, Hemmelgarn B, Moher D, Hutton B, Straus SE.

Syst Rev. 2013 Jun 28;2:46. doi: 10.1186/2046-4053-2-46.

2.
4.

Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: protocol for a systematic review and network meta-analysis.

Tricco AC, Ashoor HM, Soobiah C, Hemmelgarn B, Moher D, Hutton B, Yu CH, Majumdar SR, Straus SE.

Syst Rev. 2013 Sep 10;2:73. doi: 10.1186/2046-4053-2-73.

5.

Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials.

Salvo N, Doble B, Khan L, Amirthevasar G, Dennis K, Pasetka M, Deangelis C, Tsao M, Chow E.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):408-17. doi: 10.1016/j.ijrobp.2010.08.060. Epub 2010 Nov 13. Review.

PMID:
21075553
6.

Use of cognitive enhancers for mild cognitive impairment: protocol for a systematic review and network meta-analysis.

Tricco AC, Soobiah C, Lillie E, Perrier L, Chen MH, Hemmelgarn B, Majumdar SR, Straus SE.

Syst Rev. 2012 May 30;1:25. doi: 10.1186/2046-4053-1-25.

7.

Efficacy of cognitive enhancers for Alzheimer's disease: protocol for a systematic review and network meta-analysis.

Tricco AC, Vandervaart S, Soobiah C, Lillie E, Perrier L, Chen MH, Hemmelgarn B, Majumdar SR, Straus SE.

Syst Rev. 2012 Jun 28;1:31. doi: 10.1186/2046-4053-1-31.

8.

Safety, effectiveness, and cost of dipeptidyl peptidase-4 inhibitors versus intermediate acting insulin for type 2 diabetes: protocol for a systematic review and network meta-analysis.

Tricco AC, Antony J, Soobiah C, Hemmelgarn B, Moher D, Hutton B, Yu CH, Majumdar SR, Straus SE.

Syst Rev. 2013 Jun 28;2:47. doi: 10.1186/2046-4053-2-47.

9.

Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review.

dos Santos LV, Souza FH, Brunetto AT, Sasse AD, da Silveira Nogueira Lima JP.

J Natl Cancer Inst. 2012 Sep 5;104(17):1280-92. doi: 10.1093/jnci/djs335. Epub 2012 Aug 21. Review.

10.

Safety and effectiveness of antiretroviral therapies for HIV-infected women and their infants and children: protocol for a systematic review and network meta-analysis.

Tricco AC, Antony J, Angeliki VA, Ashoor H, Hutton B, Hemmelgarn BR, Moher D, Finkelstein Y, Gough K, Straus SE.

Syst Rev. 2014 May 25;3:51. doi: 10.1186/2046-4053-3-51. Review.

11.

Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.

Jin Y, Sun W, Gu D, Yang J, Xu Z, Chen J.

Eur J Cancer Care (Engl). 2013 Jan;22(1):41-50. doi: 10.1111/j.1365-2354.2012.01353.x. Epub 2012 Apr 22. Review.

PMID:
22519361
12.

Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.

Phillips RS, Gopaul S, Gibson F, Houghton E, Craig JV, Light K, Pizer B.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD007786. doi: 10.1002/14651858.CD007786.pub2. Review.

PMID:
20824866
13.

Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis.

Tricco AC, Cogo E, Angeliki VA, Soobiah C, Hutton B, Hemmelgarn BR, Moher D, Finkelstein Y, Straus SE.

Syst Rev. 2014 Jun 25;3:68. doi: 10.1186/2046-4053-3-68. Review.

14.

Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review.

Tramèr MR, Reynolds DJ, Stoner NS, Moore RA, McQuay HJ.

Eur J Cancer. 1998 Nov;34(12):1836-44.

PMID:
10023303
15.

Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.

Tricco AC, Soobiah C, Hui W, Antony J, Struchkov V, Hutton B, Hemmelgarn B, Moher D, Straus SE.

BMC Pharmacol Toxicol. 2015 Jan 26;16(1):1. [Epub ahead of print]

16.

Efficacy of falls prevention interventions: protocol for a systematic review and network meta-analysis.

Tricco AC, Cogo E, Holroyd-Leduc J, Sibley KM, Feldman F, Kerr G, Majumdar SR, Jaglal S, Straus SE.

Syst Rev. 2013 Jun 6;2:38. doi: 10.1186/2046-4053-2-38.

17.

A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.

Hsu ES.

Am J Ther. 2010 Sep-Oct;17(5):476-86. doi: 10.1097/MJT.0b013e3181ea7821. Review.

PMID:
20844345
19.
20.

A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults.

Likun Z, Xiang J, Yi B, Xin D, Tao ZL.

Oncologist. 2011;16(2):207-16. doi: 10.1634/theoncologist.2010-0198. Epub 2011 Jan 31. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk